Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Brain tumor stem cells as therapeutic targets in models of glioma.

Laks DR, Visnyei K, Kornblum HI.

Yonsei Med J. 2010 Sep;51(5):633-40. doi: 10.3349/ymj.2010.51.5.633. Review.


A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.

Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, Lathia J, Frank S, Pfister S, Kool M, Taylor V.

Cancer Cell. 2015 Dec 14;28(6):730-42. doi: 10.1016/j.ccell.2015.10.008.


Glioma stem cell signaling: therapeutic opportunities and challenges.

Dietrich J, Diamond EL, Kesari S.

Expert Rev Anticancer Ther. 2010 May;10(5):709-22. doi: 10.1586/era.09.190. Review.


TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.

Liu M, Inoue K, Leng T, Guo S, Xiong ZG.

Cell Signal. 2014 Dec;26(12):2773-81. doi: 10.1016/j.cellsig.2014.08.020.


A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.

Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.

Stem Cells. 2014 Jan;32(1):301-12. doi: 10.1002/stem.1528.


RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.

Goidts V, Bageritz J, Puccio L, Nakata S, Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, Van Schaftingen E, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B.

Oncogene. 2012 Jul 5;31(27):3235-43. doi: 10.1038/onc.2011.490.


The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.

Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Nam DH, Kim H.

Mol Cells. 2010 Nov;30(5):403-8. doi: 10.1007/s10059-010-0122-z. Erratum in: Mol Cells. 2011 Feb ;31(2):199. Park, Myung-Jin [removed]; Soeda, Akio [removed].


Targeting cancer stem cells through L1CAM suppresses glioma growth.

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.

Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079.


Biology of glioma cancer stem cells.

Park DM, Rich JN.

Mol Cells. 2009 Jul 31;28(1):7-12. doi: 10.1007/s10059-009-0111-2. Review.


Cancer stem cells and the biology of brain tumors.

Flores DG, Ledur PF, Abujamra AL, Brunetto AL, Schwartsmann G, Lenz G, Roesler R.

Curr Stem Cell Res Ther. 2009 Dec;4(4):306-13. Review.


A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.

Kim RK, Kim MJ, Yoon CH, Lim EJ, Yoo KC, Lee GH, Kim YH, Kim H, Jin YB, Lee YJ, Cho CG, Oh YS, Gye MC, Suh Y, Lee SJ.

Mol Pharmacol. 2012 Sep;82(3):400-7. doi: 10.1124/mol.112.078402.


CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.

Zheng J, Li XD, Wang P, Liu XB, Xue YX, Hu Y, Li Z, Li ZQ, Wang ZH, Liu YH.

Oncotarget. 2015 Sep 22;6(28):25339-55. doi: 10.18632/oncotarget.4509.


Radioresistant glioma stem cells--therapeutic obstacle or promising target?

Chalmers AJ.

DNA Repair (Amst). 2007 Sep 1;6(9):1391-4. Review.


New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.

Zhao B, Bian EB, Li J, Li J.

J Cell Physiol. 2014 Sep;229(9):1141-7. doi: 10.1002/jcp.24540. Review.


The functional role of Notch signaling in human gliomas.

Stockhausen MT, Kristoffersen K, Poulsen HS.

Neuro Oncol. 2010 Feb;12(2):199-211. doi: 10.1093/neuonc/nop022. Review.


microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.

Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R.

Cell Cycle. 2010 Mar 15;9(6):1031-6.


Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.

Bourkoula E, Mangoni D, Ius T, Pucer A, Isola M, Musiello D, Marzinotto S, Toffoletto B, Sorrentino M, Palma A, Caponnetto F, Gregoraci G, Vindigni M, Pizzolitto S, Falconieri G, De Maglio G, Pecile V, Ruaro ME, Gri G, Parisse P, Casalis L, Scoles G, Skrap M, Beltrami CA, Beltrami AP, Cesselli D.

Stem Cells. 2014 May;32(5):1239-53. doi: 10.1002/stem.1605.


Molecular pathogenesis of malignant glial tumors.

Jones TS, Holland EC.

Toxicol Pathol. 2011 Jan;39(1):158-66. doi: 10.1177/0192623310387617.


Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.

Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q.

BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.


The role of glioma stem cells in glioma tumorigenesis.

Yin CL, Lv SQ, Chen XY, Guo H.

Front Biosci (Landmark Ed). 2014 Jan 1;19:818-24. Review.

Items per page

Supplemental Content

Support Center